Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial by Jialei Hu, Yueyue Liu, Shuo Liu, Qun Shu, Xuenan Yang, Kai Chu, Yaping Qiao, Yaling Hu, Kaiqin Wang, Hongxing Pan

Get full text